INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

SPRBSPRUCE BIOSCIENCES, INC.

CIK 0001683553

EDGAR filingsOpen in network
Disclosed transactions39
Buys / sells0 / 0
Max Insider Score31
Connections6with evidence

SPRB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
WK
Walbert KeliDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
1,700 sh
May 21, 2026May 26, 2026
traded May 21, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Ways Douglas KirkDirector, Interim Chief Medical Officer · Jan 21, 2026
  • ← Insider ofevidence
    Barretto-Ko PercivalDirector · Dec 15, 2025
  • ← Insider ofevidence
    Simpson Camilla VDirector · Dec 15, 2025
15
BP
Barretto-Ko PercivalDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A
—
1,700 sh
May 21, 2026
May 26, 2026
traded May 21, 2026
+5d
SEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
400 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
266 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

19
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
5,000 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

31
WK
Ways Douglas KirkDirector, Interim Chief Medical Officer
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,250 sh
Dec 11, 2025Jan 21, 2026
traded Dec 11, 2025
+41dSEC FORM 4

Evidence

15
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
1,666 sh
Dec 11, 2025Dec 17, 2025
traded Dec 11, 2025
+6dSEC FORM 4

Evidence

15
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
1,666 sh
Dec 11, 2025Dec 17, 2025
traded Dec 11, 2025
+6dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,480 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

21
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,196 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

16
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Tax withholding
F$61K
752 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

13
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,480 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

13
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,196 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Tax withholding
F$49K
608 sh
Dec 15, 2025Dec 17, 2025
traded Dec 15, 2025
+2dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
10.0K sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
WK
Walbert KeliDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
3,400 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
BP
Barretto-Ko PercivalDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
800 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
BP
Barretto-Ko PercivalDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
800 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
10.0K sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
173 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
173 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
309 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
309 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
362 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
362 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
133 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
133 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
400 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

9
SV
Simpson Camilla VDirector
SPRBSPRUCE BIOSCIENCES, INC.
Disposition to issuer
D—
400 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

21
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,196 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Grant or award
A—
19.8K sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

21
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
4,950 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

20
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Tax withholding
F$194K
2,194 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

13
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
1,196 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

9
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Tax withholding
F$37K
428 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

17
SB
Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER
SPRBSPRUCE BIOSCIENCES, INC.
Option exercise
M—
4,950 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Walbert KeliDirector · Dec 15, 2025
  • ← Insider ofevidence
    Szwarcberg Javier B.Director, CHIEF EXECUTIVE OFFICER · Dec 12, 2025